Sepsis Attenuates the Anabolic Response to Skeletal Muscle Contraction
Overview
Authors
Affiliations
Electrically stimulated muscle contraction is a potential clinical therapy to treat sepsis-induced myopathy; however, whether sepsis alters contraction-induced anabolic signaling is unknown. Polymicrobial peritonitis was produced by cecal ligation and puncture (CLP) in male C57BL/6 mice and time-matched, pair-fed controls (CON). At ∼24 h post-CLP, the right hindlimb was electrically stimulated via the sciatic nerve to evoke maximal muscle contractions, and the gastrocnemius was collected 2 h later. Protein synthesis was increased by muscle contraction in CON mice. Sepsis suppressed the rate of synthesis in both the nonstimulated (31%) and stimulated (57%) muscle versus CON. Contraction of muscle in CON mice increased the phosphorylation of mTORC1 (mammalian target of rapamycin [mTOR] complex 1) substrates S6K1 (70-kd ribosomal protein S6 kinase 1) Thr (8-fold), S6K1 ThrSer (7-fold) and 4E-BP1 Ser (11-fold). Sepsis blunted the contraction-induced phosphorylation of S6K1 Thr (67%), S6K1 ThrSer (46%), and 4E-BP1 Ser (85%). Conversely, sepsis did not appear to modulate protein elongation as eEF2 Thr phosphorylation was decreased similarly by muscle contraction in both groups. Mitogen-activated protein kinase signaling was discordant following contraction in septic muscle; phosphorylation of extracellular signal-regulated kinase ThrTyr and p38 ThrTyr was increased similarly in both CON and CLP mice, while sepsis prevented the contraction-induced phosphorylation of JNK ThrTyr and c-JUN Ser. The expression of interleukin 6 and tumor necrosis factor α (TNF-α) mRNA in muscle was increased by sepsis, and contraction increased TNF-α to a greater extent in muscle from septic than CON mice. Injection of the mTOR inhibitor Torin2 in separate mice confirmed that contraction-induced increases in S6K1 and 4E-BP1 were mTOR mediated. These findings demonstrate that resistance to contraction-induced anabolic signaling occurs during sepsis and is predominantly mTORC1-dependent.
The immunology of sickness metabolism.
Wensveen F, Sestan M, Polic B Cell Mol Immunol. 2024; 21(9):1051-1065.
PMID: 39107476 PMC: 11364700. DOI: 10.1038/s41423-024-01192-4.
Liu H, Pan D, Li P, Wang D, Xia B, Zhang R Adv Sci (Weinh). 2023; 10(29):e2302298.
PMID: 37551034 PMC: 10582467. DOI: 10.1002/advs.202302298.
The impact of hindlimb disuse on sepsis-induced myopathy in mice.
Laitano O, Pindado J, Valera I, Spradlin R, Murray K, Villani K Physiol Rep. 2021; 9(14):e14979.
PMID: 34309237 PMC: 8311555. DOI: 10.14814/phy2.14979.
Sepsis therapies: learning from 30 years of failure of translational research to propose new leads.
Cavaillon J, Singer M, Skirecki T EMBO Mol Med. 2020; 12(4):e10128.
PMID: 32176432 PMC: 7136965. DOI: 10.15252/emmm.201810128.
Abraham M, Kelly A, Brandwein A, Fernandes T, Leisman D, Taylor M Shock. 2019; 54(2):168-182.
PMID: 31764625 PMC: 7987105. DOI: 10.1097/SHK.0000000000001485.